UBS AM’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-154,906
| Closed | -$209K | – | 2700 |
|
|
2025
Q1 | $209K | Buy |
154,906
+15,332
| +11% | +$20.7K | ﹤0.01% | 2577 |
|
|
2024
Q4 | $1.84M | Buy |
139,574
+21,637
| +18% | +$285K | ﹤0.01% | 2092 |
|
|
2024
Q3 | $1.32M | Buy |
117,937
+455
| +0.4% | +$5.1K | ﹤0.01% | 2250 |
|
|
2024
Q2 | $1.26M | Buy |
117,482
+45,363
| +63% | +$488K | ﹤0.01% | 2255 |
|
|
2024
Q1 | $1.07M | Buy |
72,119
+8,400
| +13% | +$125K | ﹤0.01% | 1972 |
|
|
2023
Q4 | $1.15M | Hold |
63,719
| – | – | ﹤0.01% | 1952 |
|
|
2023
Q3 | $1.1M | Buy |
63,719
+30,100
| +90% | +$522K | ﹤0.01% | 1907 |
|
|
2023
Q2 | $894K | Hold |
33,619
| – | – | ﹤0.01% | 2056 |
|
|
2023
Q1 | $894K | Buy |
33,619
+20,019
| +147% | +$533K | ﹤0.01% | 2056 |
|
|
2022
Q4 | $263K | Buy |
+13,600
| New | +$263K | ﹤0.01% | 2369 |
|
|
2022
Q2 | – | Sell |
-15,199
| Closed | -$107K | – | 2750 |
|
|
2022
Q1 | $107K | Buy |
+15,199
| New | +$107K | ﹤0.01% | 2737 |
|